Trials / Completed
CompletedNCT05474586
To Evaluate the Efficacy and Safety of Collavant n2 in Individuals With Osteoarthritis of the Knee
A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Collavant n2 in Individuals With Osteoarthritis of the Knee
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 236 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
A randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of Collavant n2 in individuals with osteoarthritis of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Collavant n2 40 mg/day | 2 capsules in the morning before breakfast and 2 capsules at night before going to bed for 180 days |
| OTHER | Glucosamine hydrochloride & Chondroitin sulfate | 2 capsules in the morning before breakfast and 2 capsules at night before going to bed for 180 days |
| OTHER | Microcrystalline cellulose | 2 capsules in the morning before breakfast and 2 capsules at night before going to bed for 180 days |
Timeline
- Start date
- 2022-08-08
- Primary completion
- 2023-07-04
- Completion
- 2023-07-04
- First posted
- 2022-07-26
- Last updated
- 2023-09-06
Locations
10 sites across 1 country: India
Source: ClinicalTrials.gov record NCT05474586. Inclusion in this directory is not an endorsement.